Sign In
Buy XCUR
$2.73
-0.0100 (-0.365%)
At Close: Jun 23, 2026
Exicure EPS misses by $0.17, misses on revenue
12:04pm, Friday, 19'th Nov 2021 Seeking Alpha
Exicure, Inc. Reports Third Quarter 2021 Financial Results and Corporate Progress
12:00pm, Friday, 19'th Nov 2021 Business Wire
CHICAGO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Exicure, Inc. Reports Third Quarter 2021 Financial Results and Corporate Progress
Exicure, Inc. (XCUR) Reports Q3 Loss, Lags Revenue Estimates
09:59am, Friday, 19'th Nov 2021
Exicure, Inc. (XCUR) delivered earnings and revenue surprises of -68.75% and 559.63%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Exicure, Inc. (XCUR) on Behalf of Investors
11:00pm, Tuesday, 16'th Nov 2021 Business Wire
Glancy Prongay & Murray LLP (GPM), a leading national shareholder rights law firm, today announced that it has commenced an investigation on beh
The Law Offices of Frank R. Cruz Announces Investigation of Exicure, Inc. (XCUR) on Behalf of Investors
09:00pm, Tuesday, 16'th Nov 2021 Business Wire
LOS ANGELES--(BUSINESS WIRE)---- $XCUR #investors--The Law Offices of Frank R. Cruz Announces Investigation of Exicure, Inc. (XCUR) on Behalf of Investors
Exicure files Form 12b-25 for delay in filing quarterly report
05:06pm, Tuesday, 16'th Nov 2021 Seeking Alpha
Why Are Exicure Shares Trading At All Time Low?
01:26pm, Tuesday, 16'th Nov 2021 Benzinga
Full story available on Benzinga.com
Exicure (XCUR) Stock: Why The Price Substantially Dropped
06:33am, Tuesday, 16'th Nov 2021
The stock price of Exicure Inc (NASDAQ: XCUR) fell by over 25% pre-market today. This is why it happened.
Exicure Files Form 12b-25
10:48pm, Monday, 15'th Nov 2021 Business Wire
CHICAGO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Exicure, Inc.® (NASDAQ: XCUR) today announced that it has filed a Form 12b-25 with the U.S. Securities and Exchange Commission (the SEC) in connection with its Quarterly Report on Form 10-Q for the period ended September 30, 2021 (the Form 10-Q). Exicure, Inc. (the Company) is unable to file its Quarterly Report on Form 10-Q for the quarter ended September 30, 2021 (the Q3 2021 10-Q) with the SEC within the prescribed time period without unre
Exicure to Present at the Chardan Virtual 5th Annual Genetic Medicines Conference
05:32pm, Monday, 04'th Oct 2021
CHICAGO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Exicure today announced a presentation at the Chardan Virtual 5th Annual Genetic Medicines Conference on Tuesday, October 5, 2021.
Exicure to Participate in Upcoming Scientific Conferences
07:00am, Wednesday, 15'th Sep 2021
CHICAGO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Exicure today announced participation in TIDES USA 2021 and the 17th Annual Meeting of the Oligonucleotide Therapeutics Society.
Exicure to Participate in Upcoming Investor Conferences
07:00am, Wednesday, 01'st Sep 2021
CHICAGO, & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Exicure to Participate in Upcoming Investor Conferences.
Exicure Shares Interim Cavrotolimod Data From Early-Stage Trial In Solid Tumor Patients
02:43pm, Thursday, 05'th Aug 2021
Exicure Inc (NASDAQ: XCUR) has reported interim results from Phase 1b/2 trial evaluating cavrotolimod (AST-008) in patients with advanced or metastatic solid tumors refractory to anti-PD-(L)1 thera
Ever-Glory stock rockets to pace premarket gainers, Exicure leads most-actives list
09:20am, Monday, 02'nd Aug 2021
Shares of Ever-Glory International Group Inc. rocketed 99.1% in active trading early Monday, enough to pace all of the gainers in the premarket session, after the China-based apparel retailer and supp
XCUR Stock Increases Over 55% Pre-Market: Why It Happened
05:43am, Monday, 02'nd Aug 2021
The stock price of Exicure Inc (NASDAQ: XCUR) increased by over 55% pre-market. This is why it happened.
